| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;99:1816-1821.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Gender Differences in Survival in Advanced Heart Failure
Insights From the FIRST Study
From the University of North Carolina at Chapel Hill (K.F.A., C.A.S., T.A.S., G.G.K.); Northwestern University Medical School (M.G.), Chicago, Ill; Duke University Medical Center (C.M.O., R.M.C.), Durham, NC; The University of Texas Medical Branch at Galveston (B.U.); Ostra University Hospital and Goteborg University (K.S.), Goteborg, Sweden; St. George's Hospital Medical School (W.M.), London, UK; Hospital Universitari Vall D'Hebron (J.S.-S.), Barcelona, Spain.
Background—Previous natural history studies in broad populations of heart failure patients have associated female gender with improved survival, particularly in patients with a nonischemic etiology of ventricular dysfunction. This study investigates whether a similar survival advantage for women would be evident among patients with advanced heart failure.
Methods and Results—The study analysis is based on the Flolan International Randomized Survival Trial (FIRST) study which enrolled 471 patients (359 men and 112 women) who had evidence of end-stage heart failure with marked symptoms (60% NYHA class IV) and severe left ventricular dysfunction (left ventricular ejection fraction 18±4.9%). A Cox proportional-hazards model, adjusted for age, gender, 6-minute walk, dobutamine use at randomization, mean pulmonary artery blood pressure, and treatment assignment, showed a significant association between female gender and better survival (relative risk of death for men versus women was 2.18, 95% CI 1.39 to 3.41; P<0.001). Although formal interaction testing was negative (P=0.275), among patients with a nonischemic etiology of heart failure, the relative risk of death for men versus women was 3.08 (95% CI 1.56 to 6.09, P=0.001), whereas among those with ischemic heart disease, the relative risk of death for men versus women was 1.64 (95% CI 0.87 to 3.09, P=0.127).
Conclusions—Women with advanced heart failure appear to have better survival than men. Subgroup analysis suggests this finding is strongest among patients with a nonischemic etiology of heart failure.
Key Words: sex • heart failure • survival
This article has been cited by other articles:
 |
|
 |
|
  D. H. Kwon, C. M. Halley, Z. B. Popovic, T. P. Carrigan, V. Zysek, R. Setser, P. Schoenhagen, S. D. Flamm, R. C. Starling, and M. Y. Desai Gender differences in survival in patients with severe left ventricular dysfunction despite similar extent of myocardial scar measured on cardiac magnetic resonance Eur J Heart Fail, October 1, 2009; 11(10): 937 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Song, D. K. Moser, and T. A. Lennie Relationship of Depressive Symptoms to the Impact of Physical Symptoms on Functional Status in Women With Heart Failure Am. J. Crit. Care., July 1, 2009; 18(4): 348 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Fermin, A. Barac, S. Lee, S. P. Polster, S. Hannenhalli, T. L. Bergemann, S. Grindle, D. B. Dyke, F. Pagani, L. W. Miller, et al. Sex and Age Dimorphism of Myocardial Gene Expression in Nonischemic Human Heart Failure Circ Cardiovasc Genet, December 1, 2008; 1(2): 117 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wang, P. R. Crisostomo, T. A. Markel, Y. Wang, and D. R. Meldrum Mechanisms of Sex Differences in TNFR2-Mediated Cardioprotection Circulation, September 30, 2008; 118(14_suppl_1): S38 - S45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zhan, T. Keimig, J. Xu, E. Peterson, J. Ding, F. Wang, and X.-P. Yang Dose-dependent cardiac effect of oestrogen replacement in mice post-myocardial infarction Exp Physiol, August 1, 2008; 93(8): 982 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Haddad, L. J. Saunders, S. D. Crosby, M. Carles, F. del Monte, K. King, M. R. Bristow, F. G. Spinale, T. E. Macgillivray, M. J. Semigran, et al. Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences Physiol Genomics, April 1, 2008; 33(2): 267 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. O'Meara, T. Clayton, M. B. McEntegart, J. J.V. McMurray, I. L. Pina, C. B. Granger, J. Ostergren, E. L. Michelson, S. D. Solomon, S. Pocock, et al. Sex Differences in Clinical Characteristics and Prognosis in a Broad Spectrum of Patients With Heart Failure: Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Program Circulation, June 19, 2007; 115(24): 3111 - 3120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Xiong, C. S. Van Pelt, A. C. Elizondo-Fraire, B. Fernandez-Garcia, and G. Lozano Loss of Mdm4 Results in p53-Dependent Dilated Cardiomyopathy Circulation, June 12, 2007; 115(23): 2925 - 2930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Keyhan, S.-F. Chen, and L. Pilote Angiotensin-converting enzyme inhibitors and survival in women and men with heart failure Eur J Heart Fail, June 1, 2007; 9(6-7): 594 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Frazier, K. P. Alexander, L. K. Newby, S. Anderson, E. Iverson, M. Packer, J. Cohn, S. Goldstein, and P. S. Douglas Associations of Gender and Etiology With Outcomes in Heart Failure With Systolic Dysfunction: A Pooled Analysis of 5 Randomized Control Trials J. Am. Coll. Cardiol., April 3, 2007; 49(13): 1450 - 1458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Elmariah, L. R. Goldberg, M. T. Allen, and A. Kao Effects of Gender on Peak Oxygen Consumption and the Timing of Cardiac Transplantation J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2237 - 2242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Martinez-Selles, M. D. Munoa, E. Martinez, M. A. G. Fernandez, and E. Garcia The influence of sex on right ventricular dysfunction in patients with severely depressed left ventricular ejection fraction Eur J Heart Fail, June 1, 2006; 8(4): 400 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wang, P. Crisostomo, G. M. Wairiuko, and D. R. Meldrum Estrogen receptor-{alpha} mediates acute myocardial protection in females Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2204 - H2209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P A Mehta and M R Cowie Gender and heart failure: a population perspective Heart, May 1, 2006; 92(suppl_3): iii14 - iii18. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Stramba-Badiale, K. M. Fox, S. G. Priori, P. Collins, C. Daly, I. Graham, B. Jonsson, K. Schenck-Gustafsson, and M. Tendera Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology Eur. Heart J., April 2, 2006; 27(8): 994 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Booth, N. R. Obeid, and B. R. Lucchesi Activation of estrogen receptor-{alpha} protects the in vivo rabbit heart from ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2039 - H2047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. Adams Jr, J. H. Patterson, W. A. Gattis, C. M. O'Connor, C. R. Lee, T. A. Schwartz, and M. Gheorghiade Relationship of Serum Digoxin Concentration to Mortality and Morbidity in Women in the Digitalis Investigation Group Trial: A Retrospective Analysis J. Am. Coll. Cardiol., August 2, 2005; 46(3): 497 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Mendelsohn and R. H. Karas Molecular and Cellular Basis of Cardiovascular Gender Differences Science, June 10, 2005; 308(5728): 1583 - 1587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Perrino, S. V. Naga Prasad, M. Patel, M. J. Wolf, and H. A. Rockman Targeted Inhibition of {beta}-Adrenergic Receptor Kinase-1-Associated Phosphoinositide-3 Kinase Activity Preserves {beta}-Adrenergic Receptor Signaling and Prolongs Survival in Heart Failure Induced by Calsequestrin Overexpression J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1862 - 1870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.C. Jones, G. S. Francis, and M. S. Lauer Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1025 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jessup and I. L. Pina Is it important to examine gender differences in the epidemiology and outcome of severe heart failure? J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1247 - 1252. [Full Text] [PDF]
|
|
|
|
|
|
I. Gustafsson, B. Brendorp, M. Seibaek, H. Burchardt, P. Hildebrandt, L. Kober, C. Torp-Pedersen, and DIAMOND Study Group Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure J. Am. Coll. Cardiol., March 3, 2004; 43(5): 771 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Romo, A. C. K.-B. Amaral, and J.-L. Vincent Effect of Patient Sex on Intensive Care Unit Survival Arch Intern Med, January 12, 2004; 164(1): 61 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.S. Rumsfeld and F.A. Masoudi Sex differences: implications for heart failure care Eur. Heart J., January 2, 2004; 25(2): 101 - 103. [Full Text] [PDF]
|
|
|
|
|
|
F. Gustafsson, C. Torp-Pedersen, H. Burchardt, P. Buch, M. Seibaek, E. Kjoller, I. Gustafsson, L. Kober, and for the DIAMOND Study group Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure Eur. Heart J., January 2, 2004; 25(2): 129 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Ghali, H. J. Krause-Steinrauf, K. F. Adams Jr, S. S. Khan, Y. D. Rosenberg, C. W. Yancy Jr, J. B. Young, S. Goldman, M. A. Peberdy, and J. Lindenfeld Gender differences in advanced heart failure: insights from the BEST study J. Am. Coll. Cardiol., December 17, 2003; 42(12): 2128 - 2134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Martinez-Selles, J. A.G. Robles, L. Prieto, M. D. Munoa, E. Frades, O. Diaz-Castro, and J. Almendral Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure Eur. Heart J., November 2, 2003; 24(22): 2046 - 2053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-M. Gao, A. Agrotis, D. J. Autelitano, E. Percy, E. A. Woodcock, G. L. Jennings, A. M. Dart, and X.-J. Du Sex Hormones and Cardiomyopathic Phenotype Induced by Cardiac {beta}2-Adrenergic Receptor Overexpression Endocrinology, September 1, 2003; 144(9): 4097 - 4105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Voss, J. N. Stallone, M. Li, R. N. M. Cornelussen, P. Knuefermann, and A. A. Knowlton Gender differences in the expression of heat shock proteins: the effect of estrogen Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H687 - H692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Dash, A. G Schmidt, A. Pathak, M. J Gerst, D. Biniakiewicz, V. J Kadambi, B. D Hoit, W. T Abraham, and E. G Kranias Differential regulation of p38 mitogen-activated protein kinase mediates gender-dependent catecholamine-induced hypertrophy Cardiovasc Res, March 1, 2003; 57(3): 704 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Crabbe, K. Dipla, S. Ambati, A. Zafeiridis, J. P. Gaughan, S. R. Houser, and K. B. Margulies Gender differences in post-infarction hypertrophy in end-stage failing hearts J. Am. Coll. Cardiol., January 15, 2003; 41(2): 300 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bartnik, K. Malmberg, and L. Ryden Diabetes and the heart: compromised myocardial function -- a common challenge Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B33 - B41. [Abstract] [PDF]
|
|
|
|
|
|
J. Muntwyler, G. Abetel, C. Gruner, and F. Follath One-year mortality among unselected outpatients with heart failure Eur. Heart J., December 1, 2002; 23(23): 1861 - 1866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Heiat, C. P. Gross, and H. M. Krumholz Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials Arch Intern Med, August 12, 2002; 162(15): 1682 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Orn and K Dickstein How do heart failure patients die? Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D59 - D65. [Abstract] [PDF]
|
|
|
|
|
|
A. M Dart, X.-J. Du, and B. A Kingwell Gender, sex hormones and autonomic nervous control of the cardiovascular system Cardiovasc Res, February 15, 2002; 53(3): 678 - 687. [Full Text] [PDF]
|
|
|
|
|
|
A. Luchner, U. Brockel, M. Muscholl, H.-W. Hense, A. Doring, G. A.J Riegger, and H. Schunkert Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study Cardiovasc Res, February 15, 2002; 53(3): 720 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Simon, M. Mary-Krause, C. Funck-Brentano, and P. Jaillon Sex Differences in the Prognosis of Congestive Heart Failure : Results From the Cardiac Insufficiency Bisoprolol Study (CIBIS II) Circulation, January 23, 2001; 103(3): 375 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D Duscha, B. H Annex, S. J Keteyian, H. J. Green, M. J. Sullivan, G. P. Samsa, C. A. Brawner, F. H. Schachat, and W. E. Kraus Differences in skeletal muscle between men and women with chronic heart failure J Appl Physiol, January 1, 2001; 90(1): 280 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Diet and E. Erdmann Thromboembolism in heart failure: who should be treated? Eur J Heart Fail, December 1, 2000; 2(4): 355 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Clark Perioperative Treatment of Congestive Heart Failure Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2000; 4(4): 223 - 235. [Abstract] [PDF]
|
|
|
|
 |
|
 G. M. Felker, R. E. Thompson, J. M. Hare, R. H. Hruban, D. E. Clemetson, D. L. Howard, K. L. Baughman, and E. K. Kasper Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy N. Engl. J. Med., April 13, 2000; 342(15): 1077 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Hayward, R. P. Kelly, and P. Collins The roles of gender, the menopause and hormone replacement on cardiovascular function Cardiovasc Res, April 1, 2000; 46(1): 28 - 49. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Guerra, A. Leri, X. Wang, N. Finato, C. Di Loreto, C. A. Beltrami, J. Kajstura, and P. Anversa Myocyte Death in the Failing Human Heart Is Gender Dependent Circ. Res., October 29, 1999; 85(9): 856 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Haghighi, A. G. Schmidt, B. D. Hoit, A. G. Brittsan, A. Yatani, J. W. Lester, J. Zhai, Y. Kimura, G. W. Dorn II, D. H. MacLennan, et al. Superinhibition of Sarcoplasmic Reticulum Function by Phospholamban Induces Cardiac Contractile Failure J. Biol. Chem., June 22, 2001; 276(26): 24145 - 24152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Ghali, I. L. Pina, S. S. Gottlieb, P. C. Deedwania, J. C. Wikstrand, and on Behalf of the MERIT-HF Study Group Metoprolol CR/XL in Female Patients With Heart Failure: Analysis of the Experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF) Circulation, April 2, 2002; 105(13): 1585 - 1591. [Abstract] [Full Text] [PDF]
|
|